SynthesisBMC infectious diseases2025
The efficacy of metronidazole rinses in reducing surgical site infections and improving wound healing in patients with purulent appendicitis: a systematic review and meta-analysis.
Synthesis in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Combination of Manuka Honey and Chitosan-Based Biomaterial for the Treatment of Dehisced Wound: Case Report.Life (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate the clinical efficacy of metronidazole topical solution in preventing surgical site infections and promoting wound healing.
methodsA comprehensive literature review was conducted using PubMed, EMBASE, Cochrane Database, and China National Knowledge Base to evaluate the impact of metronidazole topical (MS) and physiological saline rinses (SS) on infection rates and wound healing in patients with septic appendicitis after treatment. Review Manager 5.0 was utilized to evaluate the outcomes of the selected studies. The impact of the selected articles was assessed through Forest plot analysis, sensitivity analysis, and bias analysis conducted on the gathered data.
resultsEight studies met the inclusion criteria. The results showed a significantly lower surgical site infection rate in the metronidazole (MS) group compared to the saline (SS) group (RR = 0.28, 100% CI [0.15, 0.51], P = 0.05, I ²= 59%). However, no significant difference was observed in grade I healing rates between the two groups (RR = 1.02, 100% CI [0.91, 1.15], P = 0.41, I ² = 0%). Similarly, there was a significant difference in grade II healing rates ((RR = 0.7, 100% CI [0.32, 1.55], P = 0.30, I² =5%). A significant heterogeneity was observed in grade III healing rates (RR = 0.56, 100% CI [0.17, 1.89], P = 0.21, I² =36%). Sensitivity analysis and funnel plots showed that the study was credible with limited publication bias.
conclusionMetronidazole topical rinse may be more effective and safer than saline rinse in treating purulent appendicitis. Local application of metronidazole to purulent appendicitis incisions is a promising approach. LIMITATIONS: The review was not registered prospectively and some included studies had moderate bias. FUTURE DIRECTIONS: Larger multicenter trials are needed to validate the efficacy of metronidazole irrigation across diverse patient populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.